Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
50
CRBG Quote, Financials, Valuation and Earnings
Last price:
$31.38
Seasonality move
:
-6.31%
Day range:
$29.97 - $31.33
52-week range:
$23.69 - $36.57
Dividend yield:
3.08%
P/E ratio:
17.87x
P/S ratio:
0.95x
P/B ratio:
1.16x
Volume:
5.8M
Avg. volume:
3.8M
1-year change:
-6.2%
Market cap:
$15.7B
Revenue:
$18.7B
EPS (TTM):
$1.74
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $14.7B | $22.1B | $25.4B | $18.6B | $18.7B | |
| Revenue Growth (YoY) | 17.14% | 49.86% | 14.89% | -26.65% | 0.53% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $519M | $578M | $550M | $417M | $429M | |
| Operating Expenses | -$1.4B | -$6.7B | -$11B | -$844M | -$3.1B | |
| Operating Income | $1.4B | $6.7B | $11B | $844M | $3.1B | |
| Net Interest Expenses | $490M | $389M | $534M | $580M | $554M | |
| EBT. Incl. Unusual Items | $851M | $10.1B | $10.5B | $940M | $2.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$15M | $1.8B | $2B | -$96M | $600M | |
| Net Income to Company | $866M | $9.2B | $8.5B | $1B | $2.2B | |
| Minority Interest in Earnings | $224M | $929M | $320M | -$68M | -$27M | |
| Net Income to Common Excl Extra Items | $866M | $8.3B | $8.5B | $1B | $2.2B | |
| Basic EPS (Cont. Ops) | $1.00 | $11.40 | $12.63 | $1.72 | $3.73 | |
| Diluted EPS (Cont. Ops) | $1.00 | $11.40 | $12.60 | $1.71 | $3.72 | |
| Weighted Average Basic Share | $645M | $645M | $646.1M | $643.3M | $598M | |
| Weighted Average Diluted Share | $645M | $645M | $647.4M | $645.2M | $599.2M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $851M | $10.1B | $10.5B | $940M | $2.8B | |
| Revenue (Reported) | $14.7B | $22.1B | $25.4B | $18.6B | $18.7B | |
| Operating Income (Reported) | $1.4B | $6.7B | $11B | $844M | $3.1B | |
| Operating Income (Adjusted) | $851M | $10.1B | $10.5B | $940M | $2.8B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $5.5B | $6.9B | $5.8B | $1.9B | $5B | |
| Revenue Growth (YoY) | -- | 24.58% | -16.75% | -66.56% | 162.4% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $144M | $130M | $107M | $172M | -- | |
| Operating Expenses | -$1.8B | -$3.3B | -$2.5B | $1.5B | -$93M | |
| Operating Income | $1.8B | $3.3B | $2.5B | -$1.5B | $93M | |
| Net Interest Expenses | $83M | $149M | $135M | $133M | $135M | |
| EBT. Incl. Unusual Items | $2B | $3.2B | $2.5B | -$1.6B | -$42M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $381M | $640M | $392M | -$407M | -$179M | |
| Net Income to Company | $1.6B | $2.5B | $2.1B | -$1.2B | -- | |
| Minority Interest in Earnings | $152M | $126M | -$32M | -$3M | -$7M | |
| Net Income to Common Excl Extra Items | $1.6B | $2.5B | $2.1B | -$1.2B | $137M | |
| Basic EPS (Cont. Ops) | $2.20 | $3.73 | $3.29 | -$2.02 | $0.27 | |
| Diluted EPS (Cont. Ops) | $2.20 | $3.72 | $3.28 | -$2.02 | $0.27 | |
| Weighted Average Basic Share | $645M | $645.7M | $639M | $587.1M | $539.1M | |
| Weighted Average Diluted Share | $645M | $646.4M | $641M | $587.1M | $540.6M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2B | $3.2B | $2.5B | -$1.6B | -$42M | |
| Revenue (Reported) | $5.5B | $6.9B | $5.8B | $1.9B | $5B | |
| Operating Income (Reported) | $1.8B | $3.3B | $2.5B | -$1.5B | $93M | |
| Operating Income (Adjusted) | $2B | $3.2B | $2.5B | -$1.6B | -$42M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $19.3B | $28.6B | $19.8B | $14.4B | $18.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $433M | $584M | $435M | $441M | -- | |
| Operating Expenses | -$5.6B | -$13.3B | -$2.6B | $2.3B | -$2B | |
| Operating Income | $5.6B | $13.3B | $2.6B | -$2.3B | $2B | |
| Net Interest Expenses | $409M | $451M | $618M | $548M | $565M | |
| EBT. Incl. Unusual Items | $5.3B | $15.8B | $2.4B | -$1.9B | $1.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $867M | $3.1B | $197M | -$535M | $379M | |
| Net Income to Company | -- | $13.3B | $2.2B | -$1.4B | -- | |
| Minority Interest in Earnings | $465M | $898M | -$7M | -$100M | $43M | |
| Net Income to Common Excl Extra Items | $4.5B | $12.7B | $2.2B | -$1.4B | $1B | |
| Basic EPS (Cont. Ops) | $6.23 | $18.29 | $3.45 | -$2.08 | $1.74 | |
| Diluted EPS (Cont. Ops) | $6.23 | $18.28 | $3.44 | -$2.08 | $1.74 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $5.3B | $15.8B | $2.4B | -$1.9B | $1.4B | |
| Revenue (Reported) | $19.3B | $28.6B | $19.8B | $14.4B | $18.2B | |
| Operating Income (Reported) | $5.6B | $13.3B | $2.6B | -$2.3B | $2B | |
| Operating Income (Adjusted) | $5.3B | $15.8B | $2.4B | -$1.9B | $1.4B | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $21.8B | $15.5B | $11.6B | $11.1B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $439M | $324M | $348M | $156M | -- | |
| Operating Expenses | -$11.5B | -$2.8B | $57M | $1.1B | -- | |
| Operating Income | $11.5B | $2.8B | -$57M | -$1.1B | -- | |
| Net Interest Expenses | $357M | $441M | $409M | $420M | -- | |
| EBT. Incl. Unusual Items | $11.2B | $2.7B | -$122M | -$1.5B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.2B | $336M | -$103M | -$324M | -- | |
| Net Income to Company | $8.6B | $2.4B | -$19M | -$1.3B | -- | |
| Minority Interest in Earnings | $281M | -$46M | -$78M | -$8M | -- | |
| Net Income to Common Excl Extra Items | $9B | $2.4B | -$19M | -$1.2B | -- | |
| Basic EPS (Cont. Ops) | $13.45 | $3.77 | -$0.01 | -$2.12 | -- | |
| Diluted EPS (Cont. Ops) | $13.44 | $3.75 | -$0.02 | -$2.12 | -- | |
| Weighted Average Basic Share | $1.9B | $1.9B | $1.8B | $1.6B | -- | |
| Weighted Average Diluted Share | $1.9B | $1.9B | $1.8B | $1.6B | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $11.2B | $2.7B | -$122M | -$1.5B | -- | |
| Revenue (Reported) | $21.8B | $15.5B | $11.6B | $11.1B | -- | |
| Operating Income (Reported) | $11.5B | $2.8B | -$57M | -$1.1B | -- | |
| Operating Income (Adjusted) | $11.2B | $2.7B | -$122M | -$1.5B | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $654M | $537M | $552M | $612M | $806M | |
| Short Term Investments | $207.2B | $204B | $161.2B | $170.9B | $63.1B | |
| Accounts Receivable, Net | $860M | $884M | $916M | $594M | $713M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $12.6B | $8.7B | $7.8B | $10.2B | $12.4B | |
| Property Plant And Equipment | $63M | $51M | $36M | $20M | $75M | |
| Long-Term Investments | $6.8B | $8.2B | $8.6B | $8.3B | $8.4B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $378.3B | $384.8B | $331B | $350.9B | $362.9B | |
| Accounts Payable | $36.8B | $35.1B | $26.6B | $26B | $24.3B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $4.9B | $12.1B | $28.1B | -$2.2B | $25.4B | |
| Long-Term Debt | $11.3B | $7.4B | $13.9B | $11.6B | $11.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $338.5B | $355.9B | $320.6B | $338.2B | $350.6B | |
| Common Stock | $6M | $6M | $6M | $6M | $7M | |
| Other Common Equity Adj | $14.7B | $10.2B | -$16.9B | -$13.5B | -$13.7B | |
| Common Equity | $37.2B | $27.1B | $9.4B | $11.8B | $11.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $2.6B | $1.8B | $939M | $869M | $864M | |
| Total Equity | $39.8B | $28.9B | $10.3B | $12.6B | $12.3B | |
| Total Liabilities and Equity | $378.3B | $384.8B | $331B | $350.9B | $362.9B | |
| Cash and Short Terms | $207.8B | $204.6B | $161.7B | $171.5B | $63.9B | |
| Total Debt | $11.3B | $7.4B | $13.9B | $11.6B | $11.4B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $382M | $569M | $530M | $316M | |
| Short Term Investments | -- | $156.2B | $156.1B | $65.5B | -- | |
| Accounts Receivable, Net | -- | $695M | $717M | $690M | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | $10.2B | $10.2B | $11.3B | $11.2B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | $323.8B | $328.7B | $371.6B | $384.8B | |
| Accounts Payable | -- | $26.6B | $24.3B | $25.9B | $24B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | $28.1B | -$1.5B | $25.9B | $24B | |
| Long-Term Debt | -- | $13.9B | $11B | $12B | $11B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $315.4B | $319.5B | $357.1B | $370.5B | |
| Common Stock | -- | $6M | $6M | $7M | $7M | |
| Other Common Equity Adj | -- | -$17.3B | -$19.3B | -$9.9B | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $862M | $890M | $834M | $780M | |
| Total Equity | -- | $8.4B | $9.3B | $14.4B | $14.3B | |
| Total Liabilities and Equity | -- | $323.8B | $328.7B | $371.6B | $384.8B | |
| Cash and Short Terms | -- | $156.6B | $156.7B | $66B | -- | |
| Total Debt | -- | $13.9B | $11B | $12B | $11B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $866M | $9.2B | $8.5B | $1B | $2.2B | |
| Depreciation & Amoritzation | $325M | $562M | $585M | $366M | $193M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.3B | $2.5B | $2.6B | $3.4B | $2.2B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | $107M | $5M | -- | |
| Cash From Investing | -$7.6B | -$1.7B | -$7.1B | -$5.4B | -$11.5B | |
| Dividends Paid (Ex Special Dividend) | $472M | $1.6B | $876M | $1.7B | $544M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.3B | $5B | $9.9B | $1.5B | $1.6B | |
| Long-Term Debt Repaid | -$2.5B | -$5.9B | -$9.5B | -$1.8B | -$1.2B | |
| Repurchase of Common Stock | -- | -- | -- | $498M | $1.8B | |
| Other Financing Activities | $4.6B | $1.7B | $5.8B | $5.2B | $11B | |
| Cash From Financing | $4.3B | -$1.1B | $4.5B | $2B | $9.5B | |
| Beginning Cash (CF) | $654M | $537M | $552M | $612M | $806M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $91M | -$317M | $32M | -$5M | $196M | |
| Ending Cash (CF) | $752M | $218M | $574M | $607M | $1B | |
| Levered Free Cash Flow | $3.3B | $2.5B | $2.6B | $3.4B | $2.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.6B | -$168M | -$1.3B | $2.2B | -- | |
| Depreciation & Amoritzation | -$9M | $123M | $20M | $61M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $429M | $471M | $767M | $1.5B | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $1.2B | -$3.8B | -$2.2B | -$1.3B | -- | |
| Dividends Paid (Ex Special Dividend) | $556M | $296M | $876M | $129M | -- | |
| Special Dividend Paid | -- | -- | $1.2M | -- | -- | |
| Long-Term Debt Issued | $976M | $86M | $763M | $685M | -- | |
| Long-Term Debt Repaid | -$1.2B | -$138M | -$911M | -$330M | -- | |
| Repurchase of Common Stock | -- | -- | $252M | $398M | -- | |
| Other Financing Activities | -$1.1B | $1.2B | $984M | $2.3B | -- | |
| Cash From Financing | -$2B | $3.5B | $1.4B | $139M | -- | |
| Beginning Cash (CF) | $537M | $552M | $612M | $806M | -- | |
| Foreign Exchange Rate Adjustment | -$1M | -$1M | -- | -- | -- | |
| Additions / Reductions | -$401M | $189M | $47M | $277M | -- | |
| Ending Cash (CF) | $135M | $740M | $659M | $1.1B | -- | |
| Levered Free Cash Flow | $429M | $471M | $767M | $1.5B | -- | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $13.3B | $2.2B | -$1.4B | -- | |
| Depreciation & Amoritzation | -- | $141M | $469M | $152M | $443M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | $2.6B | $3.1B | $1.4B | $1.6B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | $137M | $107M | $5M | -- | -- | |
| Cash From Investing | -- | -$2.1B | -$7B | -$12.3B | -$11.2B | |
| Dividends Paid (Ex Special Dividend) | -$1B | $1.1B | $1.1B | $1.3B | $521M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $10.8B | $784M | $1.6B | -- | |
| Long-Term Debt Repaid | -- | -$10.6B | -$1B | -$1.8B | -- | |
| Repurchase of Common Stock | -- | -- | $246M | $1.6B | $1.4B | |
| Other Financing Activities | -- | $3.6B | $5.4B | $9.7B | -- | |
| Cash From Financing | -- | -$996M | $4.1B | $10.8B | $9.3B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -$558M | $137M | -$34M | -$225M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | $2.6B | $3.1B | $1.4B | $1.6B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $8.5B | $1B | $2.2B | -$1.3B | -- | |
| Depreciation & Amoritzation | $273M | $366M | $193M | $382M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.6B | $3.4B | $2.2B | $140M | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | $107M | $5M | -- | -- | -- | |
| Cash From Investing | -$7.1B | -$5.4B | -$11.5B | -$9.8B | -- | |
| Dividends Paid (Ex Special Dividend) | $876M | $1.7B | $544M | $392M | -- | |
| Special Dividend Paid | -- | $1.8M | -- | -- | -- | |
| Long-Term Debt Issued | $9.9B | $1.5B | $1.6B | $52M | -- | |
| Long-Term Debt Repaid | -$9.5B | -$1.8B | -$1.2B | -$1.1B | -- | |
| Repurchase of Common Stock | -- | $498M | $1.8B | $1B | -- | |
| Other Financing Activities | $5.8B | $5.2B | $11B | $7.9B | -- | |
| Cash From Financing | $4.5B | $2B | $9.5B | $9.2B | -- | |
| Beginning Cash (CF) | $2B | $2.4B | $2.4B | $999M | -- | |
| Foreign Exchange Rate Adjustment | -$10M | -$35M | $1M | $1M | -- | |
| Additions / Reductions | $32M | -$5M | $196M | -$502M | -- | |
| Ending Cash (CF) | $2B | $2.4B | $2.6B | $498M | -- | |
| Levered Free Cash Flow | $2.6B | $3.4B | $2.2B | $140M | -- | |
Get CRBG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CRBG
Sector
P/E ratio
17.87x
12.54x
PEG ratio
0.07x
0.32x
P/B ratio
1.16x
1.15x
Price / LTM sales
0.95x
1.86x
Growth Metrics
CRBG
Sector
Revenue growth
162.4%
5.54%
Earnings growth
113.21%
11.36%
Revenue (5-year growth)
8.26%
8.68%
Earnings forecast
$1.11
$0.64
Profitability
CRBG
Sector
Profitability FY 2024
--
--
Return on invested capital
4.1%
5.2%
Return on assets
0.28%
1.03%
Return on equity
7.71%
9.91%
Earnings Date
Last Earnings Date
Nov
3
Next Earnings Date
Feb
9
Estimated Next Earnings Date
Feb
2
Balance Sheet
CRBG
Sector
Total cash
$63.2B
$407.2M
Short term investments
$63.1B
$192.4M
Total assets
$362.9B
$3.1B
Long term debt
$11B
$59.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Sell
40
BILL alert for Feb 9
Bill Holdings, Inc. [BILL] is up 1.8% over the past day.
Buy
75
PRLB alert for Feb 9
Proto Labs, Inc. [PRLB] is down 1.34% over the past day.
Sell
30
MSTR alert for Feb 9
Strategy, Inc. [MSTR] is up 0.88% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
